Atlas Trials

Use of Hydrogen Sulphide Donor (N-acetyl Cysteine) in Cases With Acute Ischemic Stroke

Clinical trial NCT07749287 · COMPLETED

Trial details

NCT number
NCT07749287
Sponsor
Helwan University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ischemic Cerebral Infarction
Start date
2021-06-01
Primary completion
2023-01-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.